MultiPlan (Claritev)
Healthcare cost managementUSA
📉 Public < $1B
Peak $11 BillionToday
−95%
from peak
- 🦄Became a unicorn2020
- 📈Peak valuation$11 Billion ’20
- 💔Became a Unitard2022
- 💸Last valuation~$566M
Current status
Public (rebranded Claritev, NYSE: CTEV); market cap a fraction of its $11B SPAC value after a ~90%+ slide and reverse split.
Live · CTEV· NYSE
as of 2026-06-29
$33.20▲ 16.74% today
≈ $566 Million market cap · −94.9% from peak
How it happened
MultiPlan provides data and analytics that health insurers use to cut medical-claims costs, and went public in October 2020 through an $11B SPAC merger with Michael Klein's Churchill Capital Corp III — one of the largest de-SPAC deals of the era. Heavy debt, customer-concentration worries and a critical short-seller report battered the stock, which fell nearly 90% from its offering price. The company later rebranded as Claritev and executed a reverse split, leaving its equity worth a small fraction of its debut value.
Source: PE Insights / Claritev / SEC ($11B enterprise value via Churchill Capital Corp III SPAC, Oct 2020; stock -89%+ from offering; rebranded Claritev (CTEV) after a reverse split)
